ClinicalTrials.Veeva

Menu

A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)

G

Guangdong Provincial People's Hospital (Guangdong Provincial Academy of Medical Sciences)

Status

Enrolling

Conditions

Hypertension
Cardiovascular Diseases

Treatments

Other: Non-interventional study

Study type

Observational

Funder types

Other

Identifiers

NCT04212455
2019343H(R2)

Details and patient eligibility

About

Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the study is to investigate the association between biomarkers and adverse outcomes in patients with hypertension.

Full description

Study population includes subjects who are hypertension, of any race or ethnicity, 18 or older years of age, and have provided written informed consent to provide whole blood specimens at one or more study visits.

Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of all-cause and cardiovascular mortality will be investigated during follow-up.

Enrollment

50,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥18 years old
  • In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension)

Exclusion criteria

  • <18 years old
  • Unsigned informed consent
  • Pregnant Women and Lactation

Trial contacts and locations

2

Loading...

Central trial contact

HUANG Yu qing, MD; Feng Ying-qing, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems